Suketu Upadhyay
Senior VP and Controller, Becton Dickinson.
Companies
- IncyteChief financial officer May 6, 2026 to now1
- Vertex PharmaceuticalsBoard member May 18, 2022 to now2
- Zimmer Biomet HoldingsChief financial officer Jul 3, 2019 to now3
- Endo International plcChief financial officer Mar 4, 2014 to Sep 27, 20164
- Becton DickinsonSenior VP and Controller Dec 2, 2011 to Nov 21, 20125
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Zimmer Biomet Holdings ZBH69,485 shares6$6.6M at $95.01Mar 6, 2026
Incyte INCY26,343 shares7$3.0M at $113.77May 4, 2026
Vertex Pharmaceuticals VRTX1,558 shares8$777.9K at $499.29May 1, 2026
Becton Dickinson BDX3,568 shares9$681.8K at $191.08Nov 21, 2012
As of each latest filing. The line shows shares held over time.
Recent filings
- May 4, 2026Granted 26,343 shares of Incyte7
- May 1, 2026Returned to company 796 shares of Vertex Pharmaceuticals8
- Mar 6, 2026Shares withheld for tax 2,029 shares at $92.54 of Zimmer Biomet Holdings6
- Mar 6, 2026Exercised options 4,559 shares of Zimmer Biomet Holdings6
- Mar 6, 2026Shares withheld for tax 4,547 shares at $92.54 of Zimmer Biomet Holdings6
- Mar 6, 2026Exercised options 10,217 shares of Zimmer Biomet Holdings6
- Feb 25, 2026Shares withheld for tax 2,832 shares at $99.51 of Zimmer Biomet Holdings10
- Feb 25, 2026Exercised options 6,364 shares of Zimmer Biomet Holdings10
- Feb 20, 2026Shares withheld for tax 2,446 shares at $98.62 of Zimmer Biomet Holdings11
- Feb 20, 2026Exercised options 5,445 shares of Zimmer Biomet Holdings11
- Nov 10, 2025Shares withheld for tax 4,731 shares at $87.73 of Zimmer Biomet Holdings12
- Nov 10, 2025Exercised options 10,632 shares of Zimmer Biomet Holdings12
- May 1, 2025Returned to company 1,001 shares of Vertex Pharmaceuticals13
- May 1, 2025Granted 796 shares of Vertex Pharmaceuticals13
- Mar 6, 2025Shares withheld for tax 2,029 shares at $104.86 of Zimmer Biomet Holdings14
- Mar 6, 2025Exercised options 4,560 shares of Zimmer Biomet Holdings14
- Feb 20, 2025Shares withheld for tax 2,423 shares at $103.46 of Zimmer Biomet Holdings15
- Feb 20, 2025Exercised options 5,446 shares of Zimmer Biomet Holdings15
- Feb 18, 2025Shares withheld for tax 8,155 shares at $101.00 of Zimmer Biomet Holdings16
- Feb 18, 2025Exercised options 21,622 shares of Zimmer Biomet Holdings16
- Nov 10, 2024Shares withheld for tax 7,097 shares at $108.48 of Zimmer Biomet Holdings17
- Nov 10, 2024Exercised options 15,948 shares of Zimmer Biomet Holdings17
- May 1, 2024Returned to company 1,168 shares of Vertex Pharmaceuticals18
- May 1, 2024Granted 1,001 shares of Vertex Pharmaceuticals18
- Mar 6, 2024Shares withheld for tax 1,919 shares at $125.82 of Zimmer Biomet Holdings19
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARIncyte, Chief financial officer
- 2SEC EDGARVertex Pharmaceuticals, Board member
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Feb 27, 2026
- 11SEC EDGARForm 4 filed Feb 24, 2026
- 12SEC EDGARForm 4 filed Nov 12, 2025
- 13SEC EDGARForm 4 filed May 5, 2025
- 14SEC EDGARForm 4 filed Mar 7, 2025
- 15SEC EDGARForm 4 filed Feb 24, 2025
- 16SEC EDGARForm 4 filed Feb 19, 2025
- 17SEC EDGARForm 4 filed Nov 12, 2024
- 18SEC EDGARForm 4 filed May 3, 2024
- 19SEC EDGARForm 4 filed Mar 8, 2024